EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular drivers of osteogenesis imperfecta: a cellular and extracellular collagen disease

Silvia Cotti iD, Wendy Pérez Franco iD, Antonella Forlino iD

Clinical Science · 23.12.2025 · 139 (24) · 1733-1768

DOI: 10.1042/cs20255642 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Science, online erschienen am 18.12.2025. Verfasst von Silvia Cotti und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, Biochemistry Unit, University of Pavia, Pavia, Italy. Hauptthemen laut MEDLINE: Osteogenesis Imperfecta, Collagen Type I, Collagen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 342 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The clinical hallmarks of osteogenesis imperfecta (OI), often referred to as ‘brittle-bone disease’, are bone fragility and skeletal deformities that are usually accompanied by extra skeletal manifestations. OI is a family of collagen I-related disorders, currently classified into 23 distinct types and 5 OI-like forms, with variable phenotypic severity ranging from mild to lethal. At the molecular level, the pathophysiology of OI is driven by alterations in collagen I structure, primarily caused by dominant mutations in collagen genes (affecting approximately 85% of patients). It can also result from dominant, recessive, or X-linked defects in proteins involved in collagen biosynthesis, extracellular matrix organization, mineralization, or bone forming cell differentiation and/or activity. This review illustrates the different OI forms from a collagen I perspective, its complex biosynthetic process is first described, followed by a classification of the OI and OI-like causative mutations grouped based on whether the resulting collagen molecule is overmodified, undermodified, or unaltered. The underlying molecular mechanisms and the consequences at cellular and extracellular levels leading to the OI phenotype are discussed. An overview is provided on how newly discovered molecular pathways altered in OI can guide the development of innovative therapies aiming at increasing bone mass and improving bone quality in OI patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Osteogenesis ImperfectaCollagen Type ICollagenHumansMutationAnimalsExtracellular MatrixPhenotype

Stichwörter der Autor:innen

bonecollagenheritable connective tissue diseaseosteogenesisosteogenesis imperfectapost-translational modificationsrare bone disorders

Substanzen

Collagen Type ICollagen

Autor:innen und Institutionen

  • Department of Molecular Medicine, Biochemistry Unit, University of Pavia, Pavia, Italy.

ORCID-Profile: Silvia Cotti, Wendy Pérez Franco, Antonella Forlino

Zitieren

APA

Cotti, S., Pérez Franco, W., & Forlino, A. (2025). Molecular drivers of osteogenesis imperfecta: a cellular and extracellular collagen disease. Clinical Science, 139(24), 1733-1768. https://doi.org/10.1042/cs20255642

Vancouver

Cotti S, Pérez Franco W, Forlino A. Molecular drivers of osteogenesis imperfecta: a cellular and extracellular collagen disease. Clinical Science. 2025;139(24):1733-1768. doi:10.1042/cs20255642

BibTeX
@article{Cotti2025,
  author = {Cotti, Silvia and Pérez Franco, Wendy and Forlino, Antonella},
  title = {Molecular drivers of osteogenesis imperfecta: a cellular and extracellular collagen disease},
  journal = {Clinical Science},
  year = {2025},
  volume = {139},
  number = {24},
  pages = {1733--1768},
  doi = {10.1042/cs20255642}
}
Kostenlos starten →